XL092 (Synonyms: XL092) |
| Katalog-Nr.GC62266 |
XL092 ist ein oral aktiver, ATP-kompetitiver Inhibitor mehrerer Rezeptortyrosinkinasen (RTKs), einschließlich MET, VEGFR2, AXL und MER, mit IC50-Werten in zellbasierten Assays von 15 nM, 1,6 nM, 3,4 nM bzw. 7,2 nM. XL092 zeigt AntitumoraktivitÄt. XL092 hat das Potenzial fÜr die Erforschung von Kinase-abhÄngigen Krankheiten und ZustÄnden.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2367004-54-2
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
XL092 is a potent inhibitor of the activity of Axl, Mer and C-Met kinase with IC50s of <10 nM, respectively. XL092 exhibits anti-tumor activity and has the potential for kinase-dependent diseases and conditions research[1].
XL092 (compound 8; 3 mg/kg; iv) has a T1/2 of 5.4 hours, a CL of 43 mL/hr•kg. XL092 (3 mg/kg; po) has a T1/2 of 7.1 hours and a Cmax of 11.4 μM for rats[1].
[1]. Lynne Canne Bannen, et al. Compounds for the treatment of kinase-dependent disorders. WO2019148044A1.
Average Rating: 5 (Based on Reviews and 37 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *